Free Trial
→ Trump’s Exec Order #14154 could be a “Millionaire-Maker” (From Paradigm Press) (Ad) Free SPRO Stock Alerts

Spero Therapeutics (SPRO) SEC Filings & 10K Form

Spero Therapeutics logo
$2.91 +0.01 (+0.34%)
Closing price 07/3/2025 03:45 PM Eastern
Extended Trading
$2.91 0.00 (0.00%)
As of 07/3/2025 04:50 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare

Recent Spero Therapeutics SEC Filings

Export to Excel
DateFilerForm TypeView
06/18/2025
4:12 PM		Spero Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/16/2025
7:24 PM		Spero Therapeutics (Issuer)
THOMAS FRANK E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2025
7:24 PM		Smith Cynthia (Reporting)
Spero Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2025
7:26 PM		Pottage John C Jr (Reporting)
Spero Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2025
7:28 PM		Spero Therapeutics (Issuer)
VINK PATRICK V.J.J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2025
7:29 PM		Jackson Scott Thomas (Reporting)
Spero Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2025
7:30 PM		Deshpande Milind (Reporting)
Spero Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2025
7:32 PM		Mahadevia Ankit (Reporting)
Spero Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2025
7:24 PM		Spero Therapeutics (Issuer)
Tregoning Kathleen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/28/2025
6:12 AM		Spero Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/06/2025
7:01 PM		Rajavelu Esther (Reporting)
Spero Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/28/2025
4:08 PM		Spero Therapeutics (Filer)
Form ARS
04/28/2025
3:29 PM		Spero Therapeutics (Filer)
Form DEFA14A
03/28/2025
3:30 PM		GSK plc (Filed by)
Spero Therapeutics (Subject)
Form SCHEDULE 13D/A
03/27/2025
4:19 PM		Spero Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/27/2025
3:30 PM		Spero Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/28/2025
4:11 PM		Spero Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/05/2025
8:04 PM		Keutzer Timothy (Reporting)
Spero Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2025
7:52 PM		Rajavelu Esther (Reporting)
Spero Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2025
7:30 PM		Mahadevia Ankit (Reporting)
Spero Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2025
7:31 PM		Shukla Sath (Reporting)
Spero Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/10/2025
6:00 AM		Spero Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2024
4:37 PM		Anson Funds Management LP (Filed by)
Spero Therapeutics (Subject)
Form SC 13G/A
11/14/2024
3:02 PM		Spero Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/29/2024
4:01 PM		Spero Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/10/2024
5:56 AM		Spero Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/29/2024
5:36 PM		Shukla Sath (Reporting)
Spero Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/29/2024
5:42 PM		Keutzer Timothy (Reporting)
Spero Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/29/2024
5:43 PM		Mahadevia Ankit (Reporting)
Spero Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/06/2024
6:56 PM		Shukla Sath (Reporting)
Spero Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NASDAQ:SPRO) was last updated on 7/5/2025 by MarketBeat.com Staff
From Our Partners
Trump’s New Order Could Boost Social Security Benefits by 400%
If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...
InvestorPlace | Sponsored
Trump’s Exec Order #14154 could be a “Millionaire-Maker”
Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...
Paradigm Press | Sponsored
White House to reset Social Security?
Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...
Altimetry | Sponsored
Elon’s NEXT Big IPO?
Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...
Banyan Hill Publishing | Sponsored
The $15 Gold Fund That Pays Up to $1,152/Month
Gold prices are breaking records. But while everyone else is fixated on headlines… They're missing somet...
Investors Alley | Sponsored
A grave, grave error.
Famed financial analyst, Porter Stansberry, calls this technology “The Final Frontier” because it holds the ke...
Porter & Company | Sponsored
Buffett’s $325 Billion Cash Problem — Solved by Gold?
A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...
Golden Portfolio | Sponsored
Crypto Is Pumping Again – Now Comes the Real Opportunity
This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...
Crypto Swap Profits | Sponsored